Anixa biosciences stock.
Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.
SAN JOSE, Calif., March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on the treatment and prevention of cancer and ...Mar 23, 2021 · SAN JOSE, Calif., March 22, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa" or the "Company"), a biotechnology company focused on the treatment and prevention of cancer and ... Chardan Capital analyst Matthew Barcus maintained a Buy rating on Anixa Biosciences (ANIX – Research Report) today and set a price target of $9.00.The company’s shares opened today at $4.12 ...Dec 1, 2023 · Anixa Biosciences Stock Price, News & Analysis (NASDAQ:ANIX) $3.27 -0.07 (-2.10%) (As of 12/1/2023 ET) Compare Today's Range $3.25 $3.43 50-Day Range $2.85 $3.64 52-Week Range $2.75 $6.45 Volume 45,375 shs Average Volume 70,005 shs Market Capitalization $101.60 million P/E Ratio N/A Dividend Yield N/A Price Target $10.50
Anixa Biosciences Incorporated (NASDAQ:ANIX) is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. ANIX stock is worth $3.39 and is down 20% YTD. ANIX stock ...Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its …
The impact on the company’s stock price was immediate, with ANIX stock experiencing a slight increase of $0.13 during trading on Friday before closing at $3.68. Despite the brief upswing in its stock price, Anixa Biosciences remains embroiled in an intricate web of market uncertainties.
18 Okt 2023 ... Anixa Biosciences; A Brief Investor Q&A With CEO and Chairman Amit Kumar, PhD. 3 views · 5 minutes ago ...more ...The projected fair value for Anixa Biosciences is US$7.24 based on 2 Stage Free Cash Flow to Equity ; Anixa Biosciences is estimated to be 41% undervalued based on current share price of US$4.25 ; When compared to theindustry average discount to fair value of 32%, Anixa Biosciences' competitors seem to be trading at a lesser discountThe Anixa Biosciences Inc. stock price fell by -0.90% on the last day (Wednesday, 29th Nov 2023) from $3.34 to $3.31.During the last trading day the stock fluctuated 5.92% from a day low at $3.20 to a day high of $3.39.The price has risen in 6 of the last 10 days and is up by 15.73% over the past 2 weeks. Volume fell on the last day …Analyst's Opinion · Consensus Rating. Anixa Biosciences has received a consensus rating of Buy. · Price Target Upside/Downside. According to analysts' consensus ...Anixa Biosciences Inc’s trailing 12-month revenue is $0.2 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.320 per share for the current fiscal year. Anixa Biosciences Inc does not currently pay a dividend.
Investors. Overview. News Releases. Events & Presentations. Stock Info. SEC Filings. Financial Reports.
Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board October 23, 2023 Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial
Dec 2, 2023 · Analyst Recommendations on Copytele Inc. HC Wainwright Adjusts Price Target on Anixa Biosciences to $12 From $11, Keeps Buy Rating. Mar. 23. MT. Chardan Adjusts Price Target on Anixa Biosciences to $9 From $8, Keeps Buy Rating. Mar. 22. MT. Chardan Initiates Anixa Biosciences With Buy Rating, $8 Price Target. Dec. 23. Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. ANIX Stock Performance. USD USD; Previous close: 3.31: 3.31: Day range: 3.235 - 3.443.235 - 3.44Year range: 2 - 62 - 6Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Anixa Biosciences Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for ANIX stock stock is $10.5, which predicts an increase of 258.36%. The lowest target is $9.00 and the highest is $12. On average, analysts rate ANIX stock stock as a strong buy.Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its CEO, Dr. Amit Kumar, will ...Nov 30, 2023 · View ANIXA BIOSCIENCES INC ANIX investment & stock information. Get the latest ANIXA BIOSCIENCES INC ANIX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
SAN JOSE, Calif., Aug. 28, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ('Anixa' or the 'Company') (NASDAQ: ANIX), a biotechnology company focused...Aug 8, 2023 · SAN JOSE - Anixa Biosciences, Inc. ('Anixa' or the 'Company') (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has begun enrolling subjects in a treatment arm evaluating the combination of the Company's breast cancer vaccine with Keytruda (pembrolizumab). Oct 23, 2023. Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory BoardThe cell therapy being evaluated in Anixa's Phase 1 study differs from traditional CAR-T therapy in that it targets the FSHR, which research indicates is exclusively expressed on ovarian cells in healthy adult females. About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer.Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.SAN JOSE, Calif., April 28, 2022 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...Analyst Recommendations on Copytele Inc. HC Wainwright Adjusts Price Target on Anixa Biosciences to $12 From $11, Keeps Buy Rating. Mar. 23. MT. Chardan Adjusts Price Target on Anixa Biosciences to $9 From $8, Keeps Buy Rating. Mar. 22. MT. Chardan Initiates Anixa Biosciences With Buy Rating, $8 Price Target. Dec. 23.
Dec 1, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Anixa Biosciences stock is Buy based on the current 2 buy ratings for ANIX. The average twelve-month price prediction for Anixa Biosciences is $10.50 with a high price target of $12.00 and a low price target of $9.00. Learn more on ANIX's analyst rating ...
Firm. Analyst. Chardan. Matthew Barcus, Ph.D. H.C. Wainwright & Co. Yi Chen, Ph.D. Raghuram Selvaraju, Ph.D. Anixa Biosciences, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Anixa Biosciences, Inc.'s performance made by these analysts are theirs alone and do not represent …The cell therapy being evaluated in Anixa's Phase 1 study differs from traditional CAR-T therapy in that it targets the FSHR, which research indicates is exclusively expressed on ovarian cells in healthy adult females. About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of …ANIX: Anixa Biosciences broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research.Anixa Biosciences Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for ANIX stock stock is $10.5, which predicts an increase of 258.36%. The lowest target is $9.00 and the highest is $12. On average, analysts rate ANIX stock stock as a strong buy.Dec 8, 2022 · SAN JOSE, Calif., Dec. 8, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ... View ANIXA BIOSCIENCES INC ANIX investment & stock information. Get the latest ANIXA BIOSCIENCES INC ANIX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.SAN JOSE, Calif., March 30, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...
Anixa Biosciences' cash burn of US$5.8m is about 5.2% of its US$113m market capitalisation. Given that is a rather small percentage, it would probably be really easy for the company to fund another year's growth by issuing some new shares to investors, or even by taking out a loan.
Get Anixa Biosciences Inc (ANIX.PH) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments
Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that the U.S. Patent and ...The cell therapy being evaluated in Anixa's Phase 1 study differs from traditional CAR-T therapy in that it targets the FSHR, which research indicates is exclusively expressed on ovarian cells in healthy adult females. About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer.In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Anixa Biosciences (ANIX – Research Report), with a price target of $12.00. Yi …Anixa Biosciences stock has received a consensus rating of buy. The average rating score is and is based on 12 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Anixa ...Track Anixa Biosciences Inc (ANIX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsAbout Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T ...Nov 29, 2023 · Anixa Biosciences Stock (NASDAQ:ANIX), Dividends benzinga.com - June 20 at 11:45 PM 6 Analysts Have This to Say About Anixa Biosciences markets.businessinsider.com - June 19 at 5:36 PM HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target benzinga.com - June 19 at 7:36 AM SAN JOSE, Calif., April 17, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that Cleveland Clinic presented the most up-to-date data from the Phase 1 Trial of its breast cancer vaccine. The data presented showed that in the …Complete Anixa Biosciences Inc. stock information by Barron's. View real-time ANIX stock price and news, along with industry-best analysis.Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock. News provided by. Anixa Biosciences, Inc. 22 Mar, 2021, 17:18 ET. SAN JOSE, Calif., March 22, 2021 /PRNewswire ...
Research Anixa Biosciences' (Nasdaq:ANIX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and ...Stock analysis for Anixa Biosciences Inc (ITUS:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic ...Last Funding Type Grant; Also Known As ITUS Corporation; Legal Name CopyTele, Inc. Stock Symbol NASDAQ:ANIX; Company Type For Profit. Phone Number 6315495974.Instagram:https://instagram. dollar1 stocks to buy nowbank with virtual debit cardbest free stock scanners for day tradingaor ticker What is the target price for Anixa Biosciences (ANIX) stock? A The latest price target for Anixa Biosciences ( NASDAQ : ANIX ) was reported by HC Wainwright & Co. on Monday, September 18, 2023 . spdr gld stockhow to buy carnival cruise stock Investors. Overview. News Releases. Events & Presentations. Stock Info. SEC Filings. Financial Reports. best retail stocks Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.SAN JOSE, Calif., April 17, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that Cleveland Clinic presented the most up-to-date data from the Phase 1 Trial of its breast cancer vaccine. The data presented showed that in the …SAN JOSE, Calif., July 20, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that due to public health and safety concerns related to the ongoing COVID-19 global pandemic and to support the health and well-being of its stockholders, employees and others, the Company is ...